As shown in Fig. 1e, the proliferation ability of glioblastoma cells was decreased in the PABPC1(+) group, while increased in the PBAPC1(−) group compared with their nonspecific control (NC) group, respectively. The gene discussed is PABPC1; the disease is glioblastoma.